Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices
NHS hospitals in England used £30,492,859 of indicative cost of Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 2.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £1,181,841 |
| Leeds Teaching Hpls Nhs Trust | £1,082,654 |
| University Hpls Of Leicester Nhs Trust | £962,868 |
| Oxford University Hospitals Nhs Ft | £959,053 |
| Royal Free London Nhs Foundation Trust | £775,940 |
| Guy's & St Thomas' Nhs Foundation Trust | £772,889 |
| Medway Nhs Foundation Trust | £734,740 |
| Barts Health Nhs Trust | £669,125 |
| University Hospitals Plymouth Nhs Trust | £626,398 |
| Aintree University Hospital Nhs Ft | £609,613 |
The primary-care picture
Golimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Golimumab medicine page.